Close
CDMO Safety Testing 2026
Novotech

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Holista Launches Collagen Production JV With SCC in Collie

Holista Colltech Limited has entered into a binding joint...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...
- Advertisement -

Greenphire, the global leader in financial lifecycle management for clinical trials, announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up. The new budget development solution streamlines trial initiation for sponsors and CROs and eliminates guesswork during the budgeting process to deliver a smarter, more efficient workflow.

EnvisiX seamlessly integrates with eClinicalGPS, Greenphireโ€™s industry-leading site payment solution, enabling unprecedented simplicity and efficiency throughout a trial from budget creation and negotiation to management, execution, and tracking of global investigator grants.

โ€œGreenphire is dedicated to engineering workflow and data solutions that transform business processes, reducing administrative burden and improving process effectiveness at each step of the clinical trial,โ€ said Jim Murphy, Greenphire CEO. โ€œWith EnvisiX, stakeholders gain visibility and control over historically manual and fragmented budget build and negotiation workflows, ensuring improved speed and accuracy along the way.โ€

EnvisiX will enable sponsors and CROs to:

  • Have access to the most robust and contemporary investigator grant payment data in the industry
  • Simplify and streamline the budget creation and negotiation workflow for improved collaboration, transparency and management of rates, adjustments, adjudications, approvals and more
  • Benefit from an integration with the industry leading site payment solution, eClinicalGPS, providing a unified workflow from budget build and negotiation through payment execution and analysis
  • Access expert teams of local negotiators with country-level budget knowledge and international lawyers providing in-country consultation and regulatory oversight and guidance
  • Achieve or beat โ€˜First Patient Inโ€™ milestone targets by eliminating administrative burden and reducing cycle times

โ€œFor years, sponsors and CROs have expressed dissatisfaction with their study start-up processes. We have developed EnvisiX as a direct response to frustrations with the current workflows and solutions available in the market today,โ€ said Kyle Cunningham, Chief Product Officer at Greenphire. โ€œOur mission was to ensure that EnvisiX provides our customers with a streamlined and user friendly experience for building a budget and ultimately to enable maximized confidence, defensibility and end-to-end efficiency via a direct integration and feedback loop with eClinicalGPS, the industryโ€™s leading site payment solution.โ€

Company: Greenphire Inc


The global clinical leader in financial software for clinical trials. Greenphire is the leader in global clinical trial financial process automation. Greenphireโ€™s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphireโ€™s ClinCard, eClinicalGPS and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.Greenphire.com.

Send Enquiry for this story

By submitting this form you agree to allow www.worldpharmatoday.com to contact you regarding your enquiry.
See our Privacy Policy to learn more.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Holista Launches Collagen Production JV With SCC in Collie

Holista Colltech Limited has entered into a binding joint...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป